当前位置: 首页 > 期刊 > 《中国医学创新》 > 2025年第11期
编号:2317385
益心舒片联合瑞舒伐他汀治疗稳定型心绞痛合并高脂血症的临床研究
http://www.100md.com 2025年6月4日 中国医学创新 2025年第11期
     Clinical Study of Yixinshu Tablets Combined with Rosuvastatin in the Treatment of Stable Angina Pectoris Complicated with Hyperlipidemia/WANG Weixing, LI Qiankun. //Medical Innovation of China, 2025,22(11): 050-057

    [Abstract]Objective: To investigate the clinical effect of Yixinshu Tablets combined with Rosuvastatin in the treatment of stableangina pectoris (SAP)complicated with hyperlipidemia.Method:A totalof 153 patients with SAP complicated withhyperlipidemia admitted to Shijingshan Teaching Hospital of Capital Medical University (Beijing Shijingshan Hospital)from January 2022 to October 2024 were selectedand divided into the combination group,control group1 and control group 2 according to random number table, with 51 cases in each group.The combination group was treated with Yixinshu Tabletscombined with Rosuvastatin,thecontrol group l was treated with Rosuvastatin, and the control group 2 was treated withYixinshuTablets, allof whichwere treated for8 weeks. The angina pectoris symptoms effect, lipid-lowering effect, angina pectoris attack related indexes serological indexes ......

您现在查看是摘要页,全文长 22017 字符